NutriNerve 2.2
Purchase our patented formulation for supporting neural health. Please review the peer reviewed scientific references listed on this website that describe the growing body of evidence supporting the use of Alpha Lipoic Acid, Gamma-Linolenic Acid and Benfotiamine in treating neuropathy.
Health Care Professionals
If you are a health care professional, and have already registered with NeuroEffex, please enter your user name and password here. If you are not yet a registered professional, but would like to learn how to become one, please click here.
Providers Login
NeuroEffex Resources
Please review the literature supporting our patented formulation treatment for neuropathy.
(Note: a new window/tab will be open in your browser and you will be taken to a National Institutes of Health sponsored website.)
- Diabetic-Neuropathies-Update-on-Definitions-Diagnostic-Criteria-Estimations-2010
- The-Question-Is-My-Dear-Watson-Why-Did-the-Dog-Not-Bark?
- Oral-Treatment-with-a-Lipoic-Acid-Improves-Symptomatic-Diabetic-Polyneuropathy-The-Sydney-2-Trial
- The Approach to the Management of the Patient with Neuropathic Pain, 2010
- Neuropathy – The Crystal Ball for Cardiovascular Disease
- OLE-TCRM-OA-2008-Bourcier
- Effect of 4-Year Antioxidant Treatment with [alpha]-Lipoic Acid in Diabetic Polyneuropathy: The NATHAN 1 Trial ADA Scientific Session – Oral Presentation 2007
- At low doses, a gamma-linolenic acid-lipoic acid conjugate is more effective than docosahexaenoic acid-enriched phospholipids in preventing neuropathy in diabetic rats. J Nutr. 2007 Feb;137(2):368-72.
- Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther. 2005 Feb;43(2):71-7. Painful Diabetic Neuropathy